The implementation of screening for prostate cancer

Pim Leeuwen; Heidi Vugt; CH Bangma VERVALLEN

doi:10.1038/pcan.2010.14

The implementation of screening for prostate cancer

Pim Leeuwen
, Heidi Vugt
, CH Bangma VERVALLEN

Urology

Research output: Contribution to journal › Article › Academic › peer-review

13 Citations (Scopus)

Abstract

The objective of this study was to determine whether screening for prostate cancer (PC) reduces PC mortality and, if so, whether the required criteria to be introduced as a population-based screening program are satisfied. A literature review was conducted through electronic scientific databases. The screening tests, that is, PSA and digital rectal examination, have limited sensitivity and specificity for detecting PC; screening produces a beneficial stage shift and reduces PC mortality. Nevertheless, PC screening causes a large increase in the cumulative incidence, and the understanding of the economic cost and quality-of-life parameters are limited. PC screening cannot be justified yet in the context of a public health policy. Prostate Cancer and Prostatic Diseases (2010) 13, 218-227; doi:10.1038/pcan.2010.14; published online 3 August 2010

Original language	Undefined/Unknown
Pages (from-to)	218-227
Number of pages	10
Journal	Prostate Cancer and Prostatic Diseases
Volume	13
Issue number	3
DOIs	https://doi.org/10.1038/pcan.2010.14
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-03-49-01

Access to Document

10.1038/pcan.2010.14

http://hdl.handle.net/1765/20854

Cite this

@article{4df911e4d4944fa597b3e249bbf76180,

title = "The implementation of screening for prostate cancer",

abstract = "The objective of this study was to determine whether screening for prostate cancer (PC) reduces PC mortality and, if so, whether the required criteria to be introduced as a population-based screening program are satisfied. A literature review was conducted through electronic scientific databases. The screening tests, that is, PSA and digital rectal examination, have limited sensitivity and specificity for detecting PC; screening produces a beneficial stage shift and reduces PC mortality. Nevertheless, PC screening causes a large increase in the cumulative incidence, and the understanding of the economic cost and quality-of-life parameters are limited. PC screening cannot be justified yet in the context of a public health policy. Prostate Cancer and Prostatic Diseases (2010) 13, 218-227; doi:10.1038/pcan.2010.14; published online 3 August 2010",

author = "Pim Leeuwen and Heidi Vugt and \{Bangma VERVALLEN\}, CH",

year = "2010",

doi = "10.1038/pcan.2010.14",

language = "Undefined/Unknown",

volume = "13",

pages = "218--227",

journal = "Prostate Cancer and Prostatic Diseases",

issn = "1365-7852",

publisher = "Springer Nature",

number = "3",

}

TY - JOUR

T1 - The implementation of screening for prostate cancer

AU - Leeuwen, Pim

AU - Vugt, Heidi

AU - Bangma VERVALLEN, CH

PY - 2010

Y1 - 2010

N2 - The objective of this study was to determine whether screening for prostate cancer (PC) reduces PC mortality and, if so, whether the required criteria to be introduced as a population-based screening program are satisfied. A literature review was conducted through electronic scientific databases. The screening tests, that is, PSA and digital rectal examination, have limited sensitivity and specificity for detecting PC; screening produces a beneficial stage shift and reduces PC mortality. Nevertheless, PC screening causes a large increase in the cumulative incidence, and the understanding of the economic cost and quality-of-life parameters are limited. PC screening cannot be justified yet in the context of a public health policy. Prostate Cancer and Prostatic Diseases (2010) 13, 218-227; doi:10.1038/pcan.2010.14; published online 3 August 2010

AB - The objective of this study was to determine whether screening for prostate cancer (PC) reduces PC mortality and, if so, whether the required criteria to be introduced as a population-based screening program are satisfied. A literature review was conducted through electronic scientific databases. The screening tests, that is, PSA and digital rectal examination, have limited sensitivity and specificity for detecting PC; screening produces a beneficial stage shift and reduces PC mortality. Nevertheless, PC screening causes a large increase in the cumulative incidence, and the understanding of the economic cost and quality-of-life parameters are limited. PC screening cannot be justified yet in the context of a public health policy. Prostate Cancer and Prostatic Diseases (2010) 13, 218-227; doi:10.1038/pcan.2010.14; published online 3 August 2010

U2 - 10.1038/pcan.2010.14

DO - 10.1038/pcan.2010.14

M3 - Article

C2 - 20680029

SN - 1365-7852

VL - 13

SP - 218

EP - 227

JO - Prostate Cancer and Prostatic Diseases

JF - Prostate Cancer and Prostatic Diseases

IS - 3

ER -